A novel approach to the management of levodopa-induced dyskinesia using deep transcranial magnetic stimulation: A case report
Abstract
Levodopa-induced dyskinesia remains one of the most prevalent and disabling complications in patients with Parkinson's disease receiving long-term levodopa therapy. Although levodopa-induced dyskinesia can substantially impair the quality of life, therapeutic strategies are often limited to levodopa dose adjustment, amantadine, or deep brain stimulation. These treatment options may be ineffective, poorly tolerated, or declined by some patients. We applied low-frequency deep repetitive transcranial magnetic stimulation over the supplementary motor area in two patients with Parkinson’s disease and clinically significant levodopa-induced dyskinesia who had limited conventional treatment options. Both patients completed a 2-week protocol without medication changes and demonstrated short-term reductions in dyskinesia severity, as assessed using the Unified Dyskinesia Rating Scale and motor-complication measures. No serious adverse events occurred. These observations suggest that supplementary motor area–targeted deep repetitive transcranial magnetic stimulation is a feasible noninvasive neuromodulation approach for selected patients with levodopa-induced dyskinesia. However, this is a two-patient case report without sham stimulation or extended follow-up; therefore, the findings should be interpreted as preliminary and hypothesis-generating. Larger controlled studies with objective outcome measures and longer follow-up are needed to determine the efficacy, durability, and optimal…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.